Briefing: Bacterial strain breaks decades-old bottleneck in chemotherapy drug manufacturing

Recent research has identified key molecular bottlenecks that have historically limited the production capacity of doxorubicin, a vital chemotherapy agent.

The international team’s findings could lead to enhanced availability and efficiency in the manufacturing processes for this essential drug.

This breakthrough, published in Phys.org, emphasizes the importance of optimizing bacterial strains for improved drug production capabilities.